Telomerase FP Pocket Binding Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack specificity in targeting particular domains or substrate pockets of telomerase, a key enzyme involved in telomere maintenance, which is crucial for addressing diseases related to telomere length and stability.
Innovation Solution
Development of compounds that interact with the fingers-palm (FP) pocket of telomerase, modulating its activity to inhibit or stimulate telomerase function, thereby addressing various diseases including cancer and age-related disorders.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current methods are used to target telomerase, then telomerase activity can be modulated, but the methods lack specificity in targeting particular domains or substrate pockets
Solution Approach 1:
The patent applies local quality by designing compounds that specifically target the FP pocket domain of telomerase rather than the entire enzyme. The compound structure (Formula I) is engineered with specific molecular features that interact with particular amino acid residues (e.g., Phe193, Trp302, His304) within the FP pocket, providing localized and selective inhibition of telomerase activity while maintaining simplicity in the overall approach.
2Reliability
If compounds are designed to interact with the FP pocket of telomerase, then telomerase activity can be effectively modulated, but the structural requirements for such compounds increase complexity
Solution Approach 1:
The patent employs parameter changes by systematically varying the R1, R2, and R3 substituents on the core triazine ring structure of Formula I. These parameter changes allow optimization of the compound's interaction with the FP pocket while maintaining a relatively simple core structure. The substituents can be adjusted to fine-tune binding affinity and selectivity without requiring complex molecular architectures.
Data Source
AI summary
The present invention embraces compounds selected for interacting with the Fingers-Palm pocket of telomerase and use thereof for modulating the activity of telomerase and preventing or treating diseases or conditions associated with telomerase.